GemPharmatech Balance Sheet Health
Financial Health criteria checks 6/6
GemPharmatech has a total shareholder equity of CN¥2.1B and total debt of CN¥121.9M, which brings its debt-to-equity ratio to 5.9%. Its total assets and total liabilities are CN¥2.5B and CN¥395.2M respectively. GemPharmatech's EBIT is CN¥160.9M making its interest coverage ratio -5.6. It has cash and short-term investments of CN¥1.2B.
Key information
5.9%
Debt to equity ratio
CN¥121.87m
Debt
Interest coverage ratio | -5.6x |
Cash | CN¥1.19b |
Equity | CN¥2.08b |
Total liabilities | CN¥395.20m |
Total assets | CN¥2.48b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688046's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥307.6M).
Long Term Liabilities: 688046's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥87.6M).
Debt to Equity History and Analysis
Debt Level: 688046 has more cash than its total debt.
Reducing Debt: 688046's debt to equity ratio has reduced from 7.1% to 5.9% over the past 5 years.
Debt Coverage: 688046's debt is well covered by operating cash flow (78.9%).
Interest Coverage: 688046 earns more interest than it pays, so coverage of interest payments is not a concern.